Comparing timelines and evidence available to support new TB, HIV, and HCV drug approvals: The same, only different

• Allison LaHood,

  Roles Data curation, Formal analysis, Methodology, Validation, Visualization, Writing – original draft, Writing – review & editing

  Affiliation Department of Global Health and Social Medicine, Harvard Medical School, Boston, Massachusetts, United States of America

  https://orcid.org/0000-0001-8415-133X

  ⨯
• Rifat Rahman,

  Roles Data curation, Formal analysis, Methodology, Validation, Writing – original draft

  Affiliation Harvard Medical School, Boston, Massachusetts, United States of America

  ⨯
• Lindsay McKenna ,

  Contributed equally to this work with: Lindsay McKenna, Mike Frick

  Roles Conceptualization, Methodology, Writing – original draft, Writing – review & editing

  Affiliation Treatment Action Group, New York, New York, United States of America

  ⨯
• Mike Frick ,

  Contributed equally to this work with: Lindsay McKenna, Mike Frick

  Roles Conceptualization, Methodology, Writing – original draft, Writing – review & editing

  Affiliation Treatment Action Group, New York, New York, United States of America

  ⨯
• Carole D. Mitnick

  Roles Conceptualization, Methodology, Validation, Writing – review & editing

  * E-mail: carole_mitnick@hms.harvard.edu

  Affiliation Department of Global Health and Social Medicine, Harvard Medical School, Boston, Massachusetts, United States of America

  https://orcid.org/0000-0002-3455-658X

  ⨯